Citadel Advisors
NXGN

Citadel Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Citadel Advisors’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,571
Closed -$132K – 15652
2023
Q3 		$132K Sell
5,571
-139,477
-96% -$2.62M ﹤0.01% 10535
2023
Q2 		$2.35M Sell
145,048
-176,585
-55% -$2.93M ﹤0.01% 4869
2023
Q1 		$5.6M Buy
321,633
+120,694
+60% +$2.17M ﹤0.01% 3616
2022
Q4 		$3.77M Buy
+200,939
New +$3.87M ﹤0.01% 4355
2022
Q3 		– Sell
-11,452
Closed -$200K – 13939
2022
Q2 		$200K Buy
+11,452
New +$218K ﹤0.01% 10691
2022
Q1 		– Sell
-18,235
Closed -$324K – 14925
2021
Q4 		$324K Buy
+18,235
New +$293K ﹤0.01% 10759
2021
Q2 		– Sell
-15,226
Closed -$276K – 14669
2021
Q1 		$276K Sell
15,226
-12,592
-45% -$248K ﹤0.01% 11039
2020
Q4 		$507K Sell
27,818
-138,094
-83% -$2.19M ﹤0.01% 8121
2020
Q3 		$2.11M Sell
165,912
-189,745
-53% -$2.42M ﹤0.01% 4616
2020
Q2 		$3.9M Buy
355,657
+117,928
+50% +$1.22M ﹤0.01% 3434
2020
Q1 		$2.48M Buy
237,729
+189,045
+388% +$2.44M ﹤0.01% 3803
2019
Q4 		$782K Buy
48,684
+4,907
+11% +$81.1K ﹤0.01% 6048
2019
Q3 		$686K Buy
43,777
+25,000
+133% +$416K ﹤0.01% 6223
2019
Q2 		$374K Sell
18,777
-35,129
-65% -$656K ﹤0.01% 7255
2019
Q1 		$907K Sell
53,906
-131,067
-71% -$2.27M ﹤0.01% 5760
2018
Q4 		$2.8M Sell
184,973
-32,820
-15% -$563K ﹤0.01% 3633
2018
Q3 		$4.37M Sell
217,793
-57,960
-21% -$1.23M ﹤0.01% 3168
2018
Q2 		$5.38M Sell
275,753
-340,047
-55% -$5.37M ﹤0.01% 2669
2018
Q1 		$8.41M Buy
615,800
+352,411
+134% +$4.64M ﹤0.01% 1899
2017
Q4 		$3.58M Sell
263,389
-36,975
-12% -$531K ﹤0.01% 2883
2017
Q3 		$4.72M Buy
300,364
+68,172
+29% +$1.1M ﹤0.01% 2354
2017
Q2 		$4M Sell
232,192
-134,906
-37% -$2.05M ﹤0.01% 2358
2017
Q1 		$5.59M Sell
367,098
-78,675
-18% -$1.16M 0.01% 1936
2016
Q4 		$5.86M Sell
445,773
-297,382
-40% -$3.81M 0.01% 1823
2016
Q3 		$8.41M Buy
743,155
+279,867
+60% +$3.36M 0.01% 1519
2016
Q2 		$5.52M Buy
463,288
+115,938
+33% +$1.56M 0.01% 1739
2016
Q1 		$5.29M Buy
347,350
+59,955
+21% +$909K 0.01% 1708
2015
Q4 		$4.63M Buy
287,395
+52,748
+22% +$770K 0.01% 1880
2015
Q3 		$2.93M Sell
234,647
-222,777
-49% -$3.06M ﹤0.01% 2499
2015
Q2 		$7.58M Sell
457,424
-4,878
-1% -$78.6K 0.01% 1678
2015
Q1 		$7.39M Sell
462,302
-71,186
-13% -$1.18M 0.01% 1678
2014
Q4 		$8.32M Sell
533,488
-178,125
-25% -$2.6M 0.01% 1546
2014
Q3 		$9.8M Buy
711,613
+231,990
+48% +$3.52M 0.01% 1380
2014
Q2 		$7.7M Buy
479,623
+146,708
+44% +$2.32M 0.01% 1475
2014
Q1 		$5.62M Buy
332,915
+206,889
+164% +$3.75M 0.01% 1676
2013
Q4 		$2.65M Sell
126,026
-17,395
-12% -$392K ﹤0.01% 2252
2013
Q3 		$3.12M Sell
143,421
-125,729
-47% -$2.68M ﹤0.01% 1997
2013
Q2 		$5.04M Buy
+269,150
New +$4.91M 0.01% 1571

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's NXGN Position: Q4 2023 in Review

Citadel Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 5,571 shares — an estimated $132K sold.

Citadel Advisors first reported a position in NXGN in Q2 2013 and held it in 38 quarters. The position peaked at $9.8M in Q3 2014. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Citadel Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 5,571 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $132K.
  • Citadel Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
  • Citadel Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $9.8M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.